Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
Prof James Catto from the University of Sheffield described the findings as a "major breakthrough" in treating bladder cancer ...
The Independent on MSN5d
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patientsThe study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...
GlobalData on MSN5d
Pfizer’s Phase III bladder cancer therapy trial meets primary endpointThe trial showed a 'clinically meaningful' and 'statistically significant' improvement when treated with therapy plus BCG, ...
Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...
J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...
According to Bladder Cancer UK, the main symptoms of bladder cancer are: ...
BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback